Abstract

PreScription: Compounding Pharmacy Issues for 2017

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2017 - Volume 21, Number 1

Page(s): 4

Download in electronic PDF format for $75
  • PreScription: Compounding Pharmacy Issues for 2017 Page 1

Abstract

Related Keywords

  • U.S. Food and Drug Administration
  • FDA
  • Drug Quality and Security Act
  • DQSA
  • regulation
  • regulatory policy
  • state boards of pharmacy
  • pharmacy inspectors
  • pharmacy inspection
  • pharmaceutical benefit managers
  • PBM
  • pharmacy education
  • pharmacy technicians
  • regulatory overreach

Related Categories

  • BUSINESS
  • LEGAL
  • PHARMACY EDUCATION
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2017
Pg. 4
PreScription: Compounding Pharmacy Issues for 2017
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 95-102
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Author(s): Yoch Doug
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 453-463
Applying Quality of Design Concepts to Pharmacy Compounding
Author(s): Timko Robert J
Mar/Apr 2015
Pg. 104-106
Standing Together Fixing the Drug Quality and Security Act
Author(s): Miller David G
May/Jun 2022
Pg. 182-186
Art of Pharmacy v. State
Author(s): Standridge Rob
Jan/Feb 2018
Pg. 7-16
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Mar/Apr 2018
Pg. 92
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 32-33
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Author(s): Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Nov/Dec 2002
Pg. 434-437
Regulatory and Operational Issues of Founding a Compounding Pharmacy
Author(s): Smith Lisa K
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
Sep/Oct 2015
Pg. 389-390
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Author(s): Allen Loyd V Jr
Mar/Apr 2014
Pg. 101-111
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Author(s): Timko Robert J, Crooker Philip EM
Mar/Apr 2010
Pg. 134
Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding: Suggestions on How to Avoid Being Terminated from the Pharmacy Benefits Manager Network
Author(s): Levitt Jonathan E, Mizeski Todd
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 88-92
Legal & Ethical Issues for Pharmacy Websites
Author(s): King LD, Brashares Jennifer
Jan/Feb 2004
Pg. 65-72
Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy
Author(s): Greenburg Aimee R, Barnett Candace W
Sep/Oct 2013
Pg. 358-362
Compounding Pharmacies: Before and After an Inspection
Author(s): Kulkarni Darshan, Ricketts Samantha
May/Jun 2014
Pg. 208
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Author(s): Miller David G